MedPath

A study on Kana kudineer for wheezing (childhood asthma)

Phase 2
Not yet recruiting
Conditions
Moderate persistent asthma,
Registration Number
CTRI/2023/09/058061
Lead Sponsor
Government siddha medical college
Brief Summary

This is a single Non-Randomized Open Clinical Trial to study the safety and efficacy of Siddha trial drug Kana kudineer(internal) is to be given about 15 to 30 ml twice a day for 21 days.Clinical Trial conducted after conducting Pre Clinical oral Toxicity study.The Trial drug kana kudineer has mentioned in pillai pini maruthuvam part 2 .During the trial study related data will be recorded and documented.After the completion of trial all data will be statistically analysed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Cough with expectoration Dyspnea Running nose or rhinitis Chest tightness Wheezing.

Exclusion Criteria

Primary complex Hypersensitivity pneumonitis Lung abscess Cystic fibrosis Bronchiolitis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Assesed by comparing the reduction in clinical symptoms & modified asthma scale before & after treatment21 days
Secondary Outcome Measures
NameTimeMethod
Assessed by comparing the safety parameters before & after treatment21 days

Trial Locations

Locations (1)

Government siddha medical college

🇮🇳

Chennai, TAMIL NADU, India

Government siddha medical college
🇮🇳Chennai, TAMIL NADU, India
Dr Simal S
Principal investigator
8526533963
gautamsimal@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.